CD38 modifications in chronic lymphocytic leukemia: are they relevant?
- 2 September 2004
- journal article
- Published by Springer Nature in Leukemia
- Vol. 18 (10) , 1733-1735
- https://doi.org/10.1038/sj.leu.2403504
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLLLeukemia, 2003
- The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progressionBlood, 2003
- CD38 expression does not change in B-cell chronic lymphocytic leukemiaBlood, 2002
- V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemiaBlood, 2002
- Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical courseBlood, 2002
- CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the diseaseBlood, 2002
- CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemiaBritish Journal of Haematology, 2002
- CD38 expression is an important prognostic marker in chronic lymphocytic leukaemiaLeukemia, 2002
- CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemiaBlood, 2001
- Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic LeukemiaBlood, 1999